Literature DB >> 15586023

Obesity and prostate cancer.

Joseph C Presti1.   

Abstract

PURPOSE OF REVIEW: This review provides an update on research into the association between obesity and prostate cancer. RECENT
FINDINGS: The US Health Professional Study reported an inverse relationship between risk for prostate cancer and obesity in men under the age of 60 or in those with a positive family history for prostate cancer. Others found no association between obesity and risk for the disease. Regarding detection, obesity does not impact upon measurement of prostate specific antigen as a method of detecting prostate cancer; however, in a referral population there was an inverse association between detection rate and obesity. In three radical prostatectomy series, obesity was associated with worse pathological features and higher biochemical relapse rates. Possible mechanisms for the association between obesity and prostate cancer include the impact on serum testosterone, leptin, insulin-like growth factor I, and interleukin-6 levels.
SUMMARY: A growing body of evidence suggests that obesity may impact upon risk, detection and outcome with regard to prostate cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15586023     DOI: 10.1097/00042307-200501000-00004

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  4 in total

1.  Obesity and sex steroids during gonadotropin-releasing hormone agonist treatment for prostate cancer.

Authors:  Matthew R Smith
Journal:  Clin Cancer Res       Date:  2007-01-01       Impact factor: 12.531

2.  Leptin increases prostate cancer aggressiveness.

Authors:  Constanza M López Fontana; María E Maselli; Rafael F Pérez Elizalde; Nicolás A Di Milta Mónaco; Ana L Uvilla Recupero; José D López Laur
Journal:  J Physiol Biochem       Date:  2011-05-11       Impact factor: 4.158

3.  Body mass index and incidence of nonaggressive and aggressive prostate cancer: a dose-response meta-analysis of cohort studies.

Authors:  Bo Xie; Guanjun Zhang; Xiao Wang; Xin Xu
Journal:  Oncotarget       Date:  2017-09-15

4.  Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays.

Authors:  Joanna Budna-Tukan; Monika Świerczewska; Martine Mazel; Wojciech A Cieślikowski; Agnieszka Ida; Agnieszka Jankowiak; Andrzej Antczak; Michał Nowicki; Klaus Pantel; David Azria; Maciej Zabel; Catherine Alix-Panabières
Journal:  Cancers (Basel)       Date:  2019-06-10       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.